Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.

Jönsson, Göran LU ; Lood, Christian LU ; Gullstrand, Birgitta LU ; Holmström, Eva M LU ; Selander, Barbro ; Braconier, Jean Henrik LU ; Sturfelt, Gunnar LU ; Bengtsson, Anders LU and Truedsson, Lennart LU (2012) In Clinical Immunology 144(3). p.214-227
Abstract
Hereditary C2 deficiency (C2D) is an important susceptibility factor for invasive infections caused by encapsulated bacteria such as pneumococci and Haemophilus influenzae type b. The infections are mostly seen in childhood indicating that antibody-mediated acquired immunity is affected. C2D persons and healthy controls were vaccinated with ActHIB® and Pneumo23®. Analysis of specific antibodies to pneumococci serotype 6B, 7F, and 23F, and Hib was performed. Post-vaccination IgG antibodies against pneumococci serotype 6B and 23F at a concentration ≥1.0mg/L was found in similar frequency in C2D persons and controls. Post-vaccination sera from C2D persons showed poor complement-mediated opsonization and phagocytosis of pneumococci by... (More)
Hereditary C2 deficiency (C2D) is an important susceptibility factor for invasive infections caused by encapsulated bacteria such as pneumococci and Haemophilus influenzae type b. The infections are mostly seen in childhood indicating that antibody-mediated acquired immunity is affected. C2D persons and healthy controls were vaccinated with ActHIB® and Pneumo23®. Analysis of specific antibodies to pneumococci serotype 6B, 7F, and 23F, and Hib was performed. Post-vaccination IgG antibodies against pneumococci serotype 6B and 23F at a concentration ≥1.0mg/L was found in similar frequency in C2D persons and controls. Post-vaccination sera from C2D persons showed poor complement-mediated opsonization and phagocytosis of pneumococci by granulocytes when depending on classical and lectin pathway activation only, but increased (p=0.007) and equaled that of the normal controls when also alternative pathway activation was allowed due to antibody-dependent C2 bypass activation. In conclusion, the C2D persons benefited from the vaccination and achieve an increased phagocytic capacity. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Clinical Immunology
volume
144
issue
3
pages
214 - 227
publisher
Elsevier
external identifiers
  • wos:000308049100004
  • pmid:22842196
  • scopus:84864141220
  • pmid:22842196
ISSN
1521-6616
DOI
10.1016/j.clim.2012.06.008
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division of Microbiology, Immunology and Glycobiology - MIG (013025200), Division of Infection Medicine (SUS) (013008000), Department of Rheumatology (013036000)
id
76487451-3bff-45fc-b21d-29cc481a827c (old id 2966429)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/22842196?dopt=Abstract
date added to LUP
2016-04-01 10:18:46
date last changed
2022-04-20 00:58:54
@article{76487451-3bff-45fc-b21d-29cc481a827c,
  abstract     = {{Hereditary C2 deficiency (C2D) is an important susceptibility factor for invasive infections caused by encapsulated bacteria such as pneumococci and Haemophilus influenzae type b. The infections are mostly seen in childhood indicating that antibody-mediated acquired immunity is affected. C2D persons and healthy controls were vaccinated with ActHIB® and Pneumo23®. Analysis of specific antibodies to pneumococci serotype 6B, 7F, and 23F, and Hib was performed. Post-vaccination IgG antibodies against pneumococci serotype 6B and 23F at a concentration ≥1.0mg/L was found in similar frequency in C2D persons and controls. Post-vaccination sera from C2D persons showed poor complement-mediated opsonization and phagocytosis of pneumococci by granulocytes when depending on classical and lectin pathway activation only, but increased (p=0.007) and equaled that of the normal controls when also alternative pathway activation was allowed due to antibody-dependent C2 bypass activation. In conclusion, the C2D persons benefited from the vaccination and achieve an increased phagocytic capacity.}},
  author       = {{Jönsson, Göran and Lood, Christian and Gullstrand, Birgitta and Holmström, Eva M and Selander, Barbro and Braconier, Jean Henrik and Sturfelt, Gunnar and Bengtsson, Anders and Truedsson, Lennart}},
  issn         = {{1521-6616}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{214--227}},
  publisher    = {{Elsevier}},
  series       = {{Clinical Immunology}},
  title        = {{Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.}},
  url          = {{https://lup.lub.lu.se/search/files/1737710/3563538.pdf}},
  doi          = {{10.1016/j.clim.2012.06.008}},
  volume       = {{144}},
  year         = {{2012}},
}